GLOW Study: Effects of Triple Protein in Women

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Healthy Women

In brief

This single-site, randomized, blinded, placebo-controlled study will evaluate whether 4 weeks of daily Triple Support Protein powder improves glycemic control and overall well-being in healthy women aged 30-60 years. Participants will undergo baseline testing (DXA, fasting blood, standardized meal test with 2-hour glucose and insulin sampling), complete one acute supervised dose, and then consume a daily supplement for 4 weeks. During the final 14 days, participants will wear a continuous glucose monitor. Outcomes include postprandial glucose AUC, insulin sensitivity, and body composition.

Key facts

Study ID

NCT07526571

Run by

University of North Carolina, Chapel Hill

People needed

40

Starts

2026-04-01

Expected to finish

2026-12-01

Last updated by the study team

2026-04-13

Who can join

Age: 30 and older, up to 60. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Females aged 30-60 years.
• BMI 18.5-40 kg/m\^2.
• Recreationally active (≥30 min/wk moderate intensity exercise).
• Healthy and free from disease per health history questionnaire.
• Willing to abstain from caffeine, tobacco, and alcohol for 24 hours before testing days.

You may not qualify if…

• Currently supplementing whey protein.
• Pregnant or nursing.
• Lactose intolerant.
• Currently using creatine monohydrate.
• Severe hearing or speech impairment or inability to speak English

Where it is running

• Department of Exercise and Sport Science, Applied Physiology Laboratory — Chapel Hill, North Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.